Kura Oncology (KURA)
NASDAQ:KURA
Holding KURA?
Track your performance easily

Kura Oncology (KURA) Financial Statements

477 Followers

Kura Oncology Financial Overview

Kura Oncology's market cap is currently ―. The company's EPS TTM is $-2.23; its P/E ratio is -8.85; Kura Oncology is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -50.43M$ -49.13M-$ -38.20M$ -36.79M
EBITDA$ -46.83M$ -48.89M-$ -40.75M$ -38.56M
Net Income Common Stockholders$ -50.84M$ -49.52M$ -42.79M$ -38.60M$ -37.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 491.52M$ 527.12M$ 423.96M$ 452.59M$ 476.98M
Total Assets$ 515.12M$ 553.91M$ 448.94M$ 473.77M$ 494.74M
Total Debt$ 16.73M$ 16.97M$ 17.20M$ 17.42M$ 13.04M
Net Debt$ -474.79M$ -510.15M$ -406.76M$ -435.17M$ -463.94M
Total Liabilities$ 49.05M$ 48.82M$ 51.66M$ 43.83M$ 35.06M
Stockholders Equity$ 466.07M$ 505.08M$ 397.27M$ 429.94M$ 459.68M
Cash Flow-
Free Cash Flow$ -42.55M$ -48.93M-$ -29.05M$ -25.71M
Operating Cash Flow$ -42.53M$ -48.84M$ -34.31M$ -29.03M$ -25.62M
Investing Cash Flow$ 43.17M$ -95.34M$ 42.20M$ 8.56M$ -46.33M
Financing Cash Flow$ 3.04M$ 148.37M$ 691.00K$ 84.00K$ 94.01M
Currency in USD

Kura Oncology Earnings and Revenue History

Kura Oncology Debt to Assets

Kura Oncology Cash Flow

Kura Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis